Pfizer Inc's next- generation Prevnar vaccine missed some key goals in a study of its effectiveness, U.S. reviewers said in documents released on Monday.

A once-daily pill developed by Germany's Boehringer Ingelheim increased female sex drive in late-stage trials, putting the group in the frame to launch the first non-hormonal treatment for women with low libido.

Pfizer said it would pull 1,400 jobs out of New London within two years and move most of them a few miles away to a campus it owns in Groton, Conn., as a cost-cutting measure. It would leave behind the city’s biggest office complex and an adjacent swath of barren land that was cleared of dozens of homes to make room for a hotel, stores and condominiums that were never built.

After drug giant Pfizer Inc. announced that it was opening a new research center here, city officials aggressively moved to acquire surrounding land for an economic development project — triggering an epic fight over eminent domain that reached the U.S. Supreme Court and ended with residents being forced from their homes.

Drugmakers, Internet companies and nonprofits packed a hearing Thursday into what is a gray area for U.S. health regulators: how far social media can go in promoting drugs.

Analysis of a dozen published studies testing possible new uses for a Pfizer Inc. epilepsy drug found that reporting of the results was often fudged, indicating the medicine worked better than internal company documents showed.

No doubt the widespread use of solar and wind power is ideal, but it’ll be a long time before the mass adoption of those alternative energies is a reality. In the meantime, Cramer says, the US should shift its focus to natural gas.

Dutch authorities say they have banned use of a batch of Pfizer's Prevenar, or Prevnar, after three infants died within two weeks of receiving the anti-infection vaccination.

Johnson & Johnson will eliminate about 6 percent to 7 percent of its global workforce, or some 7,000 to 8,000 positions, as the diversified healthcare company restructures and seeks cost savings, the company said Tuesday.

Procter & Gamble said on Thursday profit dropped slightly in its first quarter, as consumers around the world kept tight reins on spending for such household items as laundry detergent and shavers.

Stocks retreated Tuesday after several earnings reports beat expectations but economic numbers missed their targets.  The Dow shed more than 50 points, or 0.5 percent, but still held above 10,000. The S&P and Nasdaq each lost about 0.6 percent.

Pfizer's acquisition of Wyeth will add to the pharmaceutical giant's diversity, which over time will help boost the company's stock, CEO Jeff Kindler told CNBC Tuesday.

Stocks retreated Tuesday after several earnings reports beat expectations but economic numbers missed their targets.  Apple and Caterpillar surged after their earnings blew past forecasts.

Futures were poised for a modestly higher open on the strength of more earnings surprises from some of Wall Street's leading companies.

Merck & Co. paid doctors and nurses a total of $3.7 million this summer to give talks to colleagues about the drug maker products and other health topics, Merck disclosed Monday.